Clinical Trial Update: Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) [Phase 3]

View source ↗

Summary

Phase 3 extension study protocol evaluating long-term safety and efficacy of Tulisokibart in participants with Crohn disease or Ulcerative colitis; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Tulisokibart

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn Disease, Colitis, Ulcerative | Phase 3 | Status: RECRUITING